Our process is based on the

optimized PECVD growth of MWCNTs onto pyramidally KOH-texturized silicon (100) substrates. By varying the aspect ratio of the Si pyramids, we were able to show the significant improvement of the FEE properties of the h-MWCNT cathodes, compared to their Si flat counterparts. In particular, our results show that the GSK872 concentration higher the AR of the Si pyramids, the lower the TF of the h-MWCNT cathodes. A TF value as low as 1.95 V/μm was achieved for the h-MWCNT cathodes with an AR value of 0.6 (a decrease of more than 40%, compared to MWCNT forest grown on flat Si substrates). The effectiveness of our approach is also reflected by the higher enhancement factors in both low- and high-field regimes. The prospect of a relatively easy scale up of the hierarchal structuring process developed here makes this approach highly attractive for applications where Osimertinib research buy low-cost

and large-surface cold cathodes are needed. Authors’ information LAG is currently a Ph.D. student at the Institut National de la Recherche Scientifique. His Ph.D. project focuses on the PECVD synthesis of carbon nanotubes and the study of their field-emission properties under different novel architectures (such as the hierarchal cathode-based devices reported here). He authored and/or co-authored four scientific papers so far. VLB is currently a postdoctoral researcher at the Institut National de la Recherche Scientifique, where he works on laser-based synthesis of various nanomaterials

(including carbon nanotubes and quantum dots), their optoelectronic characterizations, and integration into devices. He has particularly developed single-wall carbon nanotubes and silicon hybrid solar cells. His research contributions Mdivi1 datasheet include 12 published papers in prestigious journals and participation to more than 15 national and international conferences. SA is the president of pDevices, Inc. He received his Ph.D. in Experimental Atomic and Ionic Physics from the University of Paris-Sud (Paris XI). He has more than 20 years of Thalidomide experience in atomic and ionic physics-based instrumentation as well as in the management of industrial projects. He developed various spectrometry instruments while working at different prestigious light source labs in France, Germany, USA, and Canada. He is currently developing at pDevices innovative technologies for automatic, real-time early detection, and diagnosis and prevention of adverse health conditions. MAE is a Full Professor and the leader of the ‘NanoMat’ Group, he founded in 1998 at the Institut National de la Recherche Scientifique (INRS-EMT, Varennes, Quebec, Canada).